Neonatal diabetes mellitus (NDM) is defined as hyperglycaemia occurring in the first few weeks of life. It can be either transient (TNDM) or permanent (PNDM), and until recently, little was known about the condition. A cohort of 30 infants with a history of TNDM has been studied, and findings have suggested that NDM does not have the same aetiology as classical type 1 childhood diabetes. Uniparental isodisomy of chromosome 6 and an unbalanced duplication of paternal chromosome 6 have both been described as a genetic basis for TNDM in over 75% of the cases. In addition, cerebellar hypoplasia and Walcott-Rallison syndrome have been associated with PNDM, suggesting an autosomal recessive inheritance pattern; furthermore, a mutation in the gene insulin promoter factor 1 has been identified as a cause of pancreatic agenesis in PNDM. In the long term, TNDM may reduce beta cell functional capacity and present a predisposition to type 2 diabetes mellitus.

1.
Kitselle JFJ: Kinderheilkunde 1852;18:313.
2.
Shield JPH, Gardner RJ, Wadsworth EJK, James RS, Robinson DO, Baum JD, Temple IK: Neonatal diabetes: A study of its aetiopathology and genetic basis. Arch Dis Child 1997;76:F39–F42.
3.
von Mühlendahl KE, Herkenhoff H: Long-term course of neonatal diabetes. N Engl J Med 1995;333:704–708
4.
Gentz JCH, Cornblath M: Transient diabetes of the newborn. Adv Pediatr 1969;16:345–363.
5.
Ferguson IC: Neonatal hyperglycaemia: Case report with plasma insulin studies. Arch Dis Child 1967;42:509–513.
6.
Kuna P, Addy DP: Transient neonatal diabetes mellitus. Treatment with chlorpropamide. Am J Dis Child 1979;133:65–66.
7.
Mazzella M, Cotellessa M, Bonacci W, Bruno C, Serra G: Neonatal diabetes and DQB1 typing. Diabetes Care 1996;19:1308.
8.
Shield JPH, Howell WM, Temple IK: Neonatal diabetes. Diabetes Care 1997;20:1045–1046.
9.
Salerno MC, Gasparini N, Sandomenico ML, Franzese A, Tenore A: Two interesting cases of transient neonatal diabetes mellitus. J Pediatr Endocrinol 1994;7:47–52.
10.
Dacou-Voutetakis C, Anagnostakis D, Xanthou M: Macroglossia, transient neonatal diabetes mellitus and intrauterine growth failure: A new distinct entity? Pediatrics 1975;55:127–131.
11.
Weng EY, Moeschler JB, Graham JM Jr: Longitudinal observations on 15 children with Wiedemann-Beckwith syndrome. Am J Med Genet 1995;56:366–373.
12.
Hutchinson JH, Keay AJ, Kerr MM: Congenital temporary diabetes mellitus. Br Med J 1962;ii:436–440.
13.
Hoveyda N, Shield JPH, Garrett C, Chong WK, Beardsall K, Bentsi-Enchill E, Mallya H, Thompson MH: Neonatal diabetes mellitus and cerebellar hypoplasia/agenesis: Report of an association in three members of a consanguineous family. J Med Genet 1999;36:700–704.
14.
Atouf F, Czernichow P, Scharfmann R: Expression of neuronal traits in pancreatic beta cells. J Biol Chem 1997;272:1929–1934.
15.
Wolcott CD, Rallison ML: Infancy-onset diabetes mellitus and multiple epiphyseal dysplasia. J Pediatr 1972;80:292–297.
16.
Al-Gazali LI, Makia S, Azzam A, Hall CM: Wolcott-Rallison syndrome. Clin Dysmorphol 1995;4:227–233.
17.
Peake JE, McCrossin RB, Byrne G, Shepherd R: X-linked immune dysregulation, neonatal insulin dependent diabetes, and intractable diarrhoea. Arch Dis Child 1996;74:F195–199.
18.
Jonas M, Bell M, Eidson M, Koutouby R, Hensley G: Congenital diabetes mellitus and fatal secretory diarrhoea in two infants. J Pediatr Gastroenterol Nutr 1991:13;415–425.
19.
Christen HJ, Hanefield F, Duley JA, Simmonds HA: Distinct neurological syndrome in two brothers with hyperuricaemia. Lancet 1992;340:1167–1168.
20.
Winter WE, Maclaren NK, Riley WJ, Toskes PP, Andres J, Rosenbloom AL: Congenital pancreatic hypoplasia: A syndrome of exocrine pancreatic and endocrine insufficiency. J Pediatr 1986;109:465–468.
21.
Wright NM, Metzger DL, Borowitz SM, Clarke WL: Permanent neonatal diabetes mellitus and pancreatic exocrine insufficiency resulting from congenital pancreatic agenesis. Am J Dis Child 1993;147:607–609.
22.
Knip M, Koivisto M, Kaar M-L, Puukka R, Kouvalainen K: Pancreatic islet cell function and metabolic control in an infant with permanent neonatal diabetes. Acta Paediatr Scand 1983;72:303–307.
23.
Temple IK, James RS, Crolla JA, Sitch FL, Jacobs PA, Howell WM, Betts P, Baum JD, Shield JP: An imprinted gene(s) for diabetes? Nat Genet 1995;9:110–112.
24.
Gardner RJ, Robinson DO, Lamont L, Shield JPH, Temple IK: Paternal uniparental disomy of chromosome 6 and transient neonatal diabetes mellitus. Clin Genet 1998;54:522–525.
25.
Christian SL, Rich BH, Loebl C, Israel J, Vasa R, Kittikamron K, Spiro R, Rosenfield R, Ledbetter DH: Significance of genetic testing for paternal uniparental disomy of chromosome 6 in neonatal diabetes mellitus. J Pediatr 1999;134:42–46.
26.
Whiteford ML, Narendra A, White MP, Cooke A, Wilkinson AG, Robertson KJ, Tolmie JL: Paternal uniparental disomy for chromosome 6 causes transient neonatal diabetes. J Med Genet 1997;34:167–168.
27.
Temple IK, Gardner RJ, Robinson DO, Kibirige MS, Ferguson AW, Baum JD, Barber JC, James RS, Shield JP: Further evidence for an imprinted gene for neonatal diabetes localised to chromosome 6q22–23. Hum Mol Genet 1996;5:1117–1121.
28.
Gardner RJ, Mungall AJ, Dunham I, Barber JCK, Shield JPH, Temple IK, Robinson DO: Localisation of a gene for transient neonatal diabetes mellitus to an 18.72cR3000 interval on chromosome 6q. J Med Genet 1999;36:192–196.
29.
Pivnik EK, Qumsieyeh MB, Tharapel AT, Summitt JB, Wilroy RS: Partial duplication of the long arm of chromosome 6: A clinically recognisable syndrome. J Med Genet 1990;27:523–526.
30.
Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF: Pancreatic agenesis attributable to a single nucleotide deletion in human IPF-1 coding region. Nat Genet 1997;15:106–110.
31.
Jonsson JL, Carlsson T, Edlund T, Edlund H: Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994;371:606–609.
32.
Stoffers DA, Stanojevic V, Habener JF: Insulin promoter factor-1 gene mutation linked to early onset type 2 diabetes mellitus directs expression of dominant negative isoprotein. J Clin Invest 1998;102:232–241.
33.
Sosa-Pineda B, Chowdhury K, Torres M, Oliver G, Gruss P: The Pax 4 gene is essential for differentiation of insulin-producing β cells in the mammalian pancreas. Nature 1997;386:399–402.
34.
Stoss H, Pesch H-J, Pontz B, Otten A, Spranger J: Wolcott-Rallison syndrome, diabetes mellitus and spondyloepiphyseal dysplasia. Eur J Pediatr 1982;138:120–129.
35.
Bonthron DT, Dunlop N, Barr DGD, El Sanousi AA, Al-Gazali LI: Organisation of the human pax 4 gene and its exclusion as a candidate for the Wolcott-Rallison syndrome. J Med Genet 1998;35:288–292.
36.
Shield JPH, Baum JD: Is transient neonatal diabetes a risk factor for diabetes in later life? Lancet 1993;341:693.
37.
Shield JPH, Baum JD: Transient neonatal diabetes and later onset diabetes: A case of inherited insulin resistance. Arch Dis Child 1995;72:56–57.
38.
Weimerskirch D, Klein DJ: Recurrence of insulin-dependent diabetes mellitus after transient neonatal diabetes: A report of two cases. J Pediatr 1993;122:598–600.
39.
Vanelli M, De Fanti A, Cantoni S, Chiari G: Transient neonatal diabetes mellitus: A relapse after 10 years of complete remission. Acta Diabetol 1994;31:116–118.
40.
Gottschalk ME, Schatz DA, Clare-Salzler M, Kaufman DL, Ting GSP, Geffner ME: Permanent diabetes without serological evidence of autoimmunity after transient neonatal diabetes. Diabetes Care 1992;15:1273–1276.
41.
McGill JJ, Roberton DM: A new type of transient neonatal diabetes mellitus of infancy? Arch Dis Child 1986;61:334–336.
42.
Hales CN, Barker DJP, Clark PMS, Cox LJ, Fall C, Osmond C, Winter PD: Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991;303:1019–1022.
43.
Barlow DP: Genetic imprinting in mammals. Science 1995;270:1610–1613.
44.
Dunger DB, Ong KKL, Huxtable SJ, Sherriff A, Woods KA, Ahmed ML, Golding J, Pembrey ME, Ring S, Bennett ST, Todd JA: Association of the INS-VNTR with size at birth. ALSPAC Study Team. Nat Genet 1998;19:98–100.
45.
Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S: Mutations in the glucokinase gene of the fetus resulting in reduced birth weight. Nat Genet 1998;19:268–270.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.